NCT07127770View on ClinicalTrials.gov

A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

November 5, 2025

Study Completion Date

November 5, 2025

Conditions

Healthy Adults

Interventions

DRUG

PF-07104091

Cyclin-dependent kinase-2 inhibitor

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT07127770 - A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants | Biotech Hunter | Biotech Hunter